{"DataElement":{"publicId":"3436561","version":"1","preferredName":"Prostate Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the prostate carcinoma based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"2188757v1.0:3436516v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188757","version":"1","preferredName":"Prostate Tumor Clinical N","preferredDefinition":"Information related to clinical N stage for prostate tumor.","longName":"PRS_TUMOR_C_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5542C4E-2308-687C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified. Updated to use Property based on NCIt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3436516","version":"1","preferredName":"Prostate Cancer American Joint Committee on Cancer Edition 7 Clinical N Stage","preferredDefinition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3436516v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1","valueDescription":"Prostate Cancer cN1 TNM Finding v7","ValueMeaning":{"publicId":"3351759","version":"1","preferredName":"Prostate Cancer cN1 TNM Finding v7","longName":"3351759","preferredDefinition":"Prostate cancer with metastasis in regional lymph node(s). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cN1 TNM Finding v7","conceptCode":"C89225","definition":"Prostate cancer with metastasis in regional lymph node(s). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B65DD1CE-FF61-0EF6-E040-BB89AD435AA2","latestVersionIndicator":"Yes","beginDate":"2012-01-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-473E-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"N0","valueDescription":"Prostate Cancer cN0 TNM Finding v7","ValueMeaning":{"publicId":"3436518","version":"1","preferredName":"Prostate Cancer cN0 TNM Finding v7","longName":"3436518","preferredDefinition":"Prostate cancer with no regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cN0 TNM Finding v7","conceptCode":"C89224","definition":"Prostate cancer with no regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-474C-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-4765-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"NX","valueDescription":"Prostate Cancer cNX TNM Finding v7","ValueMeaning":{"publicId":"3436520","version":"1","preferredName":"Prostate Cancer cNX TNM Finding v7","longName":"3436520","preferredDefinition":"Prostate cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer cNX TNM Finding v7","conceptCode":"C89223","definition":"Prostate cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4772-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD6D35E8-478B-3E47-E040-BB89AD43055E","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3436515","version":"1","preferredName":"Prostate Cancer Clinical TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89206:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Clinical TNM Finding v7","conceptCode":"C89206","definition":"A clinical finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-470B-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-471C-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000013","version":"1","longName":"Prostate","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855643","version":"1","longName":"Prostate Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000014","version":"1","longName":"Prostate","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PROS_CLIN_N_ST_AJCC7","type":"Context Short Name","context":"NRG"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"ajcc_7_prostate_clinical_n","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"NCI Standards"},{"name":"MCL Path-1","type":"Alternate Question Text","description":"Clinical Stage - N","url":null,"context":"MCL"},{"name":"MCL-PCA-prostate-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer clinical regional lymph node N stage","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BD6E8CC5-35DF-CB4E-E040-BB89AD4379F2","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"COLBERTM","dateModified":"2021-09-21","changeDescription":"9/21/21 mr Added alt name, ATQ, alt def, ref doc, CSI MCL prostate. Per MCL DD.   Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}